Cantor Fitzgerald Initiates Coverage of Alector with ... - Nasdaq
| FBIOX Fund | USD 20.89 0.03 0.14% |
Slightly above 55% of Biotechnology Portfolio's investor base is interested to short. The analysis of overall sentiment of trading Biotechnology Portfolio Biotechnology mutual fund suggests that many investors are impartial at this time. Biotechnology Portfolio's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Portfolio's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
Cantor Fitzgerald Initiates Coverage of Alector with ... Nasdaq
Read at news.google.com
 |
Biotechnology Portfolio Fundamental Analysis
We analyze Biotechnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Biotechnology Portfolio is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Biotechnology Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics with similar companies.
Peers
Biotechnology Portfolio Related Equities
| FSELX | Fidelity Select | 1.69 | ||||
| FSPTX | Technology Portfolio | 1.15 | ||||
| FSCSX | Software And | 0.20 | ||||
| FSPHX | Health Care | 0.16 | ||||
| FBSOX | It Services | 0.01 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |